Search in:

Clinical Epidemiology Volume 9, 2017 - Issue

Submit an article Journal homepage

Open access

256

Views

CrossRef citations to date

Altmetric

Original Research

Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia

Katrina Wilcox Hagberg1 Boston Collaborative Drug Surveillance Program, Boston University School of Public Health, LexingtonCorrespondence[email protected]

Hozefa A Divan2 New England Research Institutes, Inc., Watertown, MA, USA

Shona C Fang2 New England Research Institutes, Inc., Watertown, MA, USA

J Curtis Nickel3 Kingston General Hospital, Queen’s University, Kingston, ON, Canada

Susan S Jick1 Boston Collaborative Drug Surveillance Program, Boston University School of Public Health, Lexington

Pages 83-91 | Published online: 10 Feb 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (15)

Konstantinos AnastassakisKonstantinos Anastassakis. 2022. Androgenetic Alopecia From A to Z. Androgenetic Alopecia From A to Z 41 75 .

Vaisnavi Thirugnanasundralingam, Robert Tasevski & Nathan Lawrentschuk. 2022. Men’s Health and Wellbeing. Men’s Health and Wellbeing 205 295 .

Cristina Pindado-Ortega, David Saceda-Corralo, Óscar M. Moreno-Arrones, Ana R. Rodrigues-Barata, Á. Hermosa-Gelbard, Pedro Jaén-Olasolo & Sergio Vañó-Galván. (2021) Effectiveness of dutasteride in a large series of patients with frontal fibrosing alopecia in real clinical practice. Journal of the American Academy of Dermatology 84:5, pages 1285-1294.
Crossref

Harsh Patel, Victor Arruarana, Lucille Yao, Xiaojiang Cui & Edward Ray. (2020) Effects of hormones and hormone therapy on breast tissue in transgender patients: a concise review. Endocrine 68:1, pages 6-15.
Crossref

Thora Majlund Kjærulff, Annette Kjær Ersbøll, Eero Pukkala, Kristian Bolin, Anders Green, Martha Emneus, Klaus Brasso, Peter Iversen & Lau Caspar Thygesen. (2020) Characteristics of finasteride users in comparison with nonusers: A Nordic nationwide study based on individual‐level data from Denmark, Finland, and Sweden. Pharmacoepidemiology and Drug Safety 29:4, pages 453-460.
Crossref

Seung Geun Lee, Pyoung Jae Park, Sung Ryul Lee, Bum Hwan Koo, Geon Young Byun, Myoung Jin Kim, Hyok Jo Kang, Sarang Kim, Beom Seok Oh & Young Hyun Lee. (2019) Influence of Postoperative Finasteride Therapy on Recurrence of Gynecomastia After Mastectomy in Men Taking Finasteride for Alopecia. American Journal of Men's Health 13:5, pages 155798831987142.
Crossref

Thomas R O’Leary, Craig D Shriver & Gary Wind. (2019) Metachronous Contralateral Male Breast Cancer: Case Report and Literature Review. Military Medicine 184:9-10, pages e581-e586.
Crossref

Qinghua Fang, Peiya Chen, Ningchao Du & Kutty Selva Nandakumar. (2019) Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia. Clinical Breast Cancer 19:5, pages e624-e636.
Crossref

Shelly L Gray & Todd P Semla. (2019) Post-finasteride syndrome. BMJ, pages l5047.
Crossref

Thora M. Kjærulff, Annette K. Ersbøll, Anders Green, Martha Emneus, Klaus Brasso, Peter Iversen, Eero Pukkala, Kristian Bolin & Lau C. Thygesen. (2019) Finasteride Use and Risk of Male Breast Cancer: A Case–Control Study Using Individual-Level Registry Data from Denmark, Finland, and Sweden. Cancer Epidemiology, Biomarkers & Prevention 28:5, pages 980-986.
Crossref

Deidre Vlotman-Novinuk. (2019) Treatment options for benign prostate enlargement. Journal of Prescribing Practice 1:3, pages 130-138.
Crossref

Jessica C. Gooch & Freya Schnabel. 2019. Clinical Algorithms in General Surgery. Clinical Algorithms in General Surgery 113 116 .

T. Bschleipfer & M. Burkart. (2018) Einfluss medikamentöser BPS-Therapie auf die sexuelle FunktionInfluence of medical BPS treatment on sexual function. Der Urologe 57:12, pages 1464-1471.
Crossref

Jiamin Wang, Shankun Zhao, Lianmin Luo, Ermao Li, Xiaohang Li & ZhiGang Zhao. (2018) 5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis. International braz j urol 44:5, pages 865-873.
Crossref

Joo Yong Lee & Kang Su Cho. (2018) Effects of 5-alpha reductase inhibitors. Current Opinion in Urology 28:3, pages 288-293.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia

Articles from other publishers (15)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia

Citations (15)

Articles from other publishers (15)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date